Texas nursing and rehab facility to pay $30,000 settlement over CNA blood test charges

Share this article:

A Texas nursing and rehabilitation facility will pay a $30,000 settlement related to charges that it denied drug test accommodations for a CNA applicant with a kidney disorder, the U.S. Equal Employment Opportunity Commission announced Friday.

In May 2013, the EEOC filed the lawsuit against The Fort Worth Center for Rehabilitation on behalf of Patsy Roberson, for allegedly violating the Americans with Disabilities Act.

In June 2011, The Fort Worth Center allegedly denied Roberson's request for a blood- or hair-based preemployment drug test after she indicated she could not do a urine-based drug screen because of her kidney disorder, a press release stated. Robertson's kidneys were removed several years ago due to kidney failure, thus disabling her from producing concentrated urine for drug screening purposes.

The interviewer allegedly told her that the job was dependent on passing the drug screening, and her conditional job offer was revoked.

The Fort Worth Center is a 136-bed for-profit facility and is managed by Skilled Healthcare.The facility had not responded to inquiries from McKnight's as of press time.

Note: An earlier version of this article listed the settlement amount as $50,000. The figure has been changed in accordance with a revised EEOC press release. 

Share this article:

More in News

Large hepatitis outbreak reaches 47 cases, podiatry company denies ManorCare's charges

The number of people infected in an infamous North Dakota Hepatitis C outbreak has risen, state health officials say.

National Quality Forum supports quality measures in bill to standardize post-acute assessments

National Quality Forum supports quality measures in bill ...

The National Quality Forum has come out in strong support of a proposed standardized quality measures, such as skin integrity, across different types of post-acute care settings. Uniform assessments are ...

CMS changes mind on hospice drugs

The Centers for Medicaid & Medicare Services has revised guidance on authorization of hospice drugs for those under Medicare Advantage and Part D plans, according to a new memo.